Market by Product, Application, End-user, and Country | Forecast 2021-2028
Triton’s research on the Europe digital genome market depicts that this industry will grow at a CAGR of 9.30% in terms of revenue during the forecast years from 2021 to 2028.
Report scope can be customized per your requirements. Request For Customization
The
countries evaluated in the report on this market include:
• Germany
• The United Kingdom
• France
• Spain
• Russia
• Italy
• Rest of Europe countries
Germany
is considered the largest biotechnology hub in Europe and across the world,
thanks to the presence of numerous biotechnology companies in the country,
high-tech research laboratories, and massive funding to carry out R&D
activities. The nation boasts of having the highest number of biotech companies
in the region, and is also a prominent name internationally considering the
number of studies in the pipeline. The high-quality research infrastructure
present in Germany and the cutting-edge technology it uses are creating a
lucrative opportunity for the growth of the digital genome market.
Whereas,
in France, national-level genomic organizations are working on improving the
genomics and bioinformatics platforms in the country. For instance, France
Genomique is focused on maintaining high-performance research for the
production and analysis of genomics data. The healthcare infrastructure offers
superior skills, expertise, and support to the nation’s scientific community.
In addition, the International Symposium on Human Genomics was held in France
in February 2020 to share the experiences of some of the best French teams
working in the field. All the above-stated factors provide a beneficial
scenario for the growth of the French digital genome market in the coming
years.
Biomeriux
SA is a France-based company providing products and solutions for the diagnosis
and management of cardiovascular diseases, infectious diseases, and targeted
cancers. The healthcare segment of the company caters to pharmaceutical
companies, hospitals, medical clinics, dental & orthodontic practitioners,
health information systems, and food manufacturing & testing. The company
operates through its subsidiaries and a vast network of distributors.
BioMerieux is headquartered in Marcy l’Etoile, France. The strong research and
development capabilities of the company enable it to develop innovative
products to boost revenue. Also, Biomeriux’s investments in R&D have
increased, as compared to the previous years.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1.
EUROPE DIGITAL GENOME MARKET -
SUMMARY
2.
INDUSTRY OUTLOOK
2.1. PORTER’S
FIVE FORCES MODEL
2.1.1. THREAT
OF NEW ENTRANTS
2.1.2. THREAT
OF SUBSTITUTE PRODUCTS
2.1.3. BARGAINING
POWER OF BUYERS
2.1.4. BARGAINING
POWER OF SUPPLIERS
2.1.5. COMPETITIVE
RIVALRY
2.2. IMPACT
OF COVID-19 ON DIGITAL GENOME MARKET
2.3. MARKET
ATTRACTIVENESS INDEX
2.4. VENDOR
LANDSCAPE
2.5. KEY
INSIGHTS
2.6. KEY
DRIVERS
2.6.1. PROLIFERATING
BURDEN OF CHRONIC DISEASES
2.6.2. CONTINUOUS
FUNDING BY THE MANUFACTURERS AND GOVERNMENT IN THE FIELD OF GENOMICS
2.7. KEY
RESTRAINTS
2.7.1. SECURITY
RISKS ASSOCIATED WITH DIGITAL GENOME
2.7.2. LACK
OF SKILLED PROFESSIONALS IN THE FIELD OF GENOME TECHNOLOGY
2.8. KEY
OPPORTUNITIES
2.8.1. TECHNOLOGICAL
ADVANCEMENTS
2.8.2. PREVAILING
AWARENESS IN THE DEVELOPING ECONOMIES REGARDING DNA SEQUENCING TECHNOLOGIES
3.
DIGITAL GENOME MARKET OUTLOOK
- BY PRODUCT
3.1. SEQUENCING
AND ANALYZER INSTRUMENTS
3.2. DNA/RNA
ANALYSIS
3.3. SEQUENCING
AND ANALYSIS SOFTWARE
3.4. SEQUENCING
CHIPS
3.5. SAMPLE
PREP INSTRUMENTS
4.
DIGITAL GENOME MARKET OUTLOOK
- BY APPLICATION
4.1. DIAGNOSTICS
4.2. DRUG
DISCOVERY
4.3. ACADEMIC
RESEARCH
4.4. PERSONALIZED
MEDICINE
4.5. AGRICULTURAL
4.6. OTHER
APPLICATIONS
5.
DIGITAL GENOME MARKET OUTLOOK
- BY END-USER
5.1. DIAGNOSTICS
AND FORENSIC LABS
5.2. ACADEMIC
RESEARCH INSTITUTES
5.3. HOSPITALS
5.4. OTHER
END-USERS
6.
DIGITAL GENOME MARKET - EUROPE
6.1. COUNTRY
ANALYSIS
6.1.1. GERMANY
6.1.2. FRANCE
6.1.3. THE
UNITED KINGDOM
6.1.4. ITALY
6.1.5. RUSSIA
6.1.6. SPAIN
6.1.7. REST
OF EUROPE
7.
COMPANY PROFILE
7.1. QIAGEN
NV
7.2. OXFORD
NANOPORE TECHNOLOGIES LTD
7.3. BECTON,
DICKINSON, AND COMPANY (BD)
7.4. ILLUMINA
INC
7.5. THERMO
FISHER SCIENTIFIC INC
7.6. PACIFIC
BIOSCIENCE
7.7. BIO-RAD
LABORATORIES INC
7.8. F.
HOFFMANN-LA ROCHE
7.9. PERKINELMER
INC
7.10. REGENERON
PHARMACEUTICALS
7.11. BIOMERIEUX
SA
7.12. ABBOTT
LABORATORIES
7.13. AGILENT
TECHNOLOGIES INC.
7.14. INSCRIPTA
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE
1: EUROPE DIGITAL GENOME MARKET, BY
COUNTRY, 2021-2028 (IN $ MILLION)
TABLE
2: VENDOR LANDSCAPE
TABLE
3: EUROPE DIGITAL GENOME MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE
4: EUROPE DIGITAL GENOME MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE
5: EUROPE DIGITAL GENOME MARKET, BY
END-USER, 2021-2028 (IN $ MILLION)
TABLE
6: EUROPE DIGITAL GENOME MARKET, BY
COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE
1: EUROPE DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE
2: EUROPE DIGITAL GENOME MARKET, BY
SEQUENCING AND ANALYZER INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE
3: EUROPE DIGITAL GENOME MARKET, BY
DNA/RNA ANALYSIS, 2021-2028 (IN $ MILLION)
FIGURE
4: EUROPE DIGITAL GENOME MARKET, BY
SEQUENCING AND ANALYSIS SOFTWARE, 2021-2028 (IN $ MILLION)
FIGURE
5: EUROPE DIGITAL GENOME MARKET, BY
SEQUENCING CHIPS, 2021-2028 (IN $ MILLION)
FIGURE
6: EUROPE DIGITAL GENOME MARKET, BY
SAMPLE PREP INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE
7: EUROPE DIGITAL GENOME MARKET, BY
DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE
8: EUROPE DIGITAL GENOME MARKET, BY
DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE
9: EUROPE DIGITAL GENOME MARKET, BY
ACADEMIC RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE
10: EUROPE DIGITAL GENOME MARKET, BY PERSONALIZED
MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE
11: EUROPE DIGITAL GENOME MARKET, BY
AGRICULTURAL, 2021-2028 (IN $ MILLION)
FIGURE
12: EUROPE DIGITAL GENOME MARKET, BY
OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE
13: EUROPE DIGITAL GENOME MARKET, BY
DIAGNOSTICS AND FORENSIC LABS, 2021-2028 (IN $ MILLION)
FIGURE
14: EUROPE DIGITAL GENOME MARKET, BY
ACADEMIC RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE
15: EUROPE DIGITAL GENOME MARKET, BY
HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE
16: EUROPE DIGITAL GENOME MARKET, BY
OTHER END-USERS, 2021-2028 (IN $ MILLION)
FIGURE
17: EUROPE DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE
18: GERMANY DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE
19: FRANCE DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE
20: THE UNITED KINGDOM DIGITAL GENOME
MARKET 2021-2028 (IN $ MILLION)
FIGURE
21: ITALY DIGITAL GENOME MARKET 2021-2028
(IN $ MILLION)
FIGURE
22: RUSSIA DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE
23: SPAIN DIGITAL GENOME MARKET 2021-2028
(IN $ MILLION)
FIGURE
24: REST OF EUROPE DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)